[Skip to Content]
[Skip to Content Landing]

Hemoglobin A1c Targets in Type 2 Diabetes

This video summarizes the rationale for and controversies surrounding recommendations made by the Clinical Guidelines Committee of the American College of Physicians (ACP) in its 2018 Guidance Statement on hemoglobin A1c (HbA1c) targets for glycemic control with pharmacology therapy for nonpregnant adults with type 2 diabetes. Elizabeth L. Tung, MD, MS, and Neda Laiteerapong, MD, MS, both of the Chicago Center for Diabetes Translation Research in the Section of General Internal Medicine at the University of Chicago, explain.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close